HATFIELD, Pa. & WYNNEWOOD, Pa — Genisphere and the nonprofit Lankenau Institute for Medical Research (LIMR), which are already making progress together on identifying Inflammatory Bowel Disease biomarkers, have partnered to develop nanotherapeutics targeting cancers and eye diseases. “LIMR is fortunate to partner with Genisphere for the development of its cancer nanotherapies,” said George Prendergast, […]
Shenzen, China, and Hilden, Germany, –QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that China’s State Food and Drug Administration (SFDA) has approved QIAGEN’s careHPV Test and instrument platform. The careHPV Test is the first molecular diagnostic to screen for high risk human papillomavirus (HPV) designed for low-resource clinical settings, such as areas […]
inForm® Image Analysis Software is a patented automated image analysis package for accurately quantifying biomarker expression in tumors and surrounding tissues. The software program is available in two packages: inForm Tissue Finder™ and inForm Cell Analysis™. The inForm Tissue Finder software operates with the Vectra™ intelligent multispectral slide analysis systems and is a powerful research […]
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, announced today that it has opened a new office in Tarrytown, New York to support and grow its CytoSure™ cytogenetics arrays and Genefficiency™ next generation sequencing business in the US. The new office will enable OGT to provide hands-on […]
Toronto, Ontario, – SQI Diagnostics Inc. (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has established a Special Committee to review possible strategic transactions, determine appropriate responses, as well as other options available to optimize benefits to the Corporation and its […]
REYKJAVIK, Iceland – deCODE Genetics and Illumina, global leaders in analyzing and understanding the human genome, together with scientists from the National Hospital of Iceland and collaborators from Holland, Germany and the United States, reported today in the New England Journal of Medicine the identification of just the second gene variant found to confer high […]
Flagship qPCR instrument offers reliability, accuracy, ease of use and flexibility for IVD and lab-developed diagnostic tests Life Technologies Corporation (NASDAQ:LIFE) today announced the launch of its Applied Biosystems QuantStudio™ Dx Real-Time PCR Instrument designed to meet the specific needs of clinical diagnostic laboratories. The instrument is CE-IVD marked for use in Europe and represents […]
Hitachi Chemical Co., Ltd. (Head Office: Tokyo; President and CEO: Kazuyuki Tanaka; Capital: 15.5 billion yen; hereinafter referred to as “Hitachi Chemical”), in the field of life sciences, developed a novel mRNA quantitative assay called “Hem(A)+ System”(*1). This is a simple, high-throughput, reproducible method, that offers a wide range of applications in clinical biomarker discovery […]
Marcy l’Etoile (France) and Lexington, MA (U.S.) –— bioMérieux and Quanterix announced today that they have entered into a strategic agreement that gives bioMérieux worldwide exclusive rights to Quanterix’s Simoa technology in clinical laboratories and for industrial applications. Under the agreement, Quanterix will deliver a new instrument and consumables based on its Simoa technology. bioMérieux […]
Munich, Germany, – Definiens AG, the leader in image analysis for Digital Pathology, today announced that Dr. Gerald Möller, has joined the company’s supervisory board as an independent member and has been appointed chairman. Following the recent financing round, Dr. Möller will guide the expansion of Definiens’ current business and the development and commercialization of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
